Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy.
Ontology highlight
ABSTRACT: Human breast cancer treatment regimens have evolved greatly due to the significant advances in understanding the molecular mechanisms and pathways of the common subtypes of breast cancer. In this review, we discuss recent progress in breast cancer targeted therapy and immunotherapy as well as ongoing clinical trials. We also highlight the potential of combination therapies and personalized approaches to improve clinical outcomes. Targeted therapies have surpassed the hormone receptors and the human epidermal growth factor receptor 2 (HER2) to include many other molecules in targetable pathways such as the epidermal growth factor receptor (EGFR), poly (adenosine diphosphate-ribose) polymerase (PARP), and cyclin-dependent kinase 4/6 (CDK4/6). However, resistance to targeted therapy persists,
SUBMITTER: Bou-Dargham MJ
PROVIDER: S-EPMC8558657 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA